ID: ALA5269725

Max Phase: Preclinical

Molecular Formula: C23H24O4

Molecular Weight: 364.44

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)O/C(=C\c1ccc(OCCC3CCCC3)cc1)C2=O

Standard InChI:  InChI=1S/C23H24O4/c1-25-19-10-11-20-21(15-19)27-22(23(20)24)14-17-6-8-18(9-7-17)26-13-12-16-4-2-3-5-16/h6-11,14-16H,2-5,12-13H2,1H3/b22-14-

Standard InChI Key:  FLBPTMUXVNGHSH-HMAPJEAMSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 364.44Molecular Weight (Monoisotopic): 364.1675AlogP: 5.27#Rotatable Bonds: 6
Polar Surface Area: 44.76Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.92CX LogD: 4.92
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -0.21

References

1. Guglielmi P, Mathew B, Secci D, Carradori S..  (2020)  Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors.,  205  [PMID:32920430] [10.1016/j.ejmech.2020.112650]

Source